Global Business Development Director @ (February 2023 - February 2026)
Medical and Commercial Head (ANZ) @ (November 2020 - September 2023)
Associate Director of Business Development (Scientific Collaborations and Partnerships) @ (July 2019 - November 2020)
Scientist - (Cancer ImmunoTherapeutics) @ (May 2015 - June 2017)
Research Scientist @ (May 2011 - August 2014)
Research Scientist (Human Immune Monitoring Center) @ (October 2008 - April 2011)
Research Associate II @ iZumi (acquired by iperian; acquired by Bristol-Myers Squibb) (April 2008 - October 2008)
Research Associate II @ (August 2006 - April 2008)
Lab Technician @ Caltag Laboratories (acquired by Invitrogen - then Life Technologies now Thermo
Lab Technician @ Caltag Laboratories (acquired by Invitrogen - then Life Technologies now Thermo (January 2002 - January 2006)
Bioprocess Technician @ (June 2002 - August 2002)
Fernando S Education
San Francisco State University
Bachelor's degree (Cell Biology)
2004-2006
Fernando S Skills
antibody development
Single Cell Sequencing
Oncology Clinical Research
Private Equity Funding
Cancer Research
International Business Development
New Business Development
Customer Relationship Management (CRM)
Presentation Skills
Sales Operations
Project Management
Negotiation
Training
Stakeholder Management
Problem Solving
Networking
Client Relations
Multi-color Flow Cytometry
Mammalian Cell Culture
Immunology
Fernando S Summary
Fernando S, based in Sydney, NSW, AU, is currently a Independent Consultant at BioConsultant. Fernando S brings experience from previous roles at Partillion Bioscience, Guardant Health AMEA, InterVenn Biosciences and Pfizer. Fernando S holds a 2004 - 2006 Bachelor's degree in Cell Biology @ San Francisco State University. With a robust skill set that includes antibody development, Single Cell Sequencing, Oncology Clinical Research, Private Equity Funding, Cancer Research and more. Fernando S has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Fernando S?
Find contact details for 700 million professionals.